Volume 19, Issue 3 pp. 360-368

Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women

M. BRUNO md

Corresponding Author

M. BRUNO md

Experimental Oncology Department, Cancer Institute of Bari, Bari, Italy

Michele BRUNO, Experimental Oncology Department, Cancer Institute of Bari, Bari, Italy (e-mail: [email protected]). Search for more papers by this author
M. DIGENNARO md

M. DIGENNARO md

Unit of Senology, Woman Department, Cancer Institute of Bari, Bari

Search for more papers by this author
S. TOMMASI bs

S. TOMMASI bs

Experimental Oncology Department, Cancer Institute of Bari, Bari, Italy

Search for more papers by this author
B. STEA msis

B. STEA msis

Experimental Oncology Department, Cancer Institute of Bari, Bari, Italy

Search for more papers by this author
T. DANESE psyd

T. DANESE psyd

Experimental Oncology Department, Cancer Institute of Bari, Bari, Italy

Search for more papers by this author
F. SCHITTULLI md

F. SCHITTULLI md

Unit of Senology, Woman Department, Cancer Institute of Bari, Bari

Search for more papers by this author
A. PARADISO md

A. PARADISO md

Experimental Oncology Department, Cancer Institute of Bari, Bari, Italy

Search for more papers by this author
First published: 14 April 2010
Citations: 11

Abstract

BRUNO M., DIGENNARO M., TOMMASI S., STEA B., DANESE T., SCHITTULLI F. & PARADISO A. (2010) European Journal of Cancer Care19, 360–368
Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women

The objective of this study is to evaluate women's awareness and interest in genetic testing for breast cancer risk, to identify socio-demographic factors, to analyse the reasons for wanting or not wanting to be tested and finally to determine whether breast cancer patients and healthy women have different attitudes towards genetic testing. Consecutive series of 879 women without and with breast cancer participated in a 20-item self-completing questionnaire. Among breast cancer patients, 57% answered that they would definitely or probably accept being tested, compared with 84% of women without breast cancer. At the multiple logistic regression analysis only to have a diagnosis of breast cancer conditioned significantly the interest to have genetic testing. Surprisingly, a family history of breast cancer was found to have no significant impact. The most frequently cited reason for being interested in genetic testing was ‘to learn about your children's risk’. Although women's awareness about breast cancer genes is inadequate, the interest in genetic testing is substantial and higher both in healthy women and in women with breast cancer. These results provide important indications for the development of educational strategies.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.